Evidence And Education Must Support US Biosimilars
Misinformation ‘Continues To Be A Challenge’, Acknowledges Cardinal’s Oskouei
Executive Summary
In the second part of an exclusive interview with Generics Bulletin, Cardinal Health’s vice president of biosimilars, Sonia Oskouei, talks about the importance of real-world evidence and education in ensuring confidence in biosimilars, as well as the ongoing struggle against misinformation and the need for clarity over concepts such as interchangeability and unbranded biologics.